Modeling and Monte Carlo simulations in oral drug absorption

Basic and Clinical Pharmacology and Toxicology

Volumn 96, Issue 3, 2005, Pages 200-205

  Dokoumetzidis, Aristides ^a   Kosmas, Kosmidis ^b   Argyrakis, Panos ^b   Macheras, Panos ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CAFFEINE; CARBAMAZEPINE; CHLOROTHIAZIDE; CHLORPHENIRAMINE; CIMETIDINE; CLONIDINE; CORTICOSTEROID; DESIPRAMINE; DEXAMETHASONE; DIAZEPAM; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; FUROSEMIDE; GANCICLOVIR; GLYCINE; GRISEOFULVIN; HYDROCHLOROTHIAZIDE; HYDROCORTISONE; INDOMETACIN; KETOPROFEN; MANNITOL; METOPROLOL; NAPROXEN; PANADIPLON; PHENYTOIN; UNINDEXED DRUG;

AQUEOUS SOLUTION; CONFERENCE PAPER; DRUG ABSORPTION; DRUG CLASSIFICATION; DRUG DOSE; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG UPTAKE; GASTROINTESTINAL TRACT; INTESTINE; INTESTINE TRANSIT TIME; MATHEMATICAL MODEL; MONTE CARLO METHOD; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PHARMACEUTICS; PHYSICAL CHEMISTRY; PHYSIOLOGY; POPULATION MODEL; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; REGULATORY MECHANISM; SOLID STATE; STOMACH PH;

ADMINISTRATION, ORAL; ANIMALS; HUMANS; INTESTINAL ABSORPTION; MODELS, BIOLOGICAL; MONTE CARLO METHOD; PHARMACOKINETICS; SOLUBILITY;

EID: 15244344293     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2005.pto960309.x     Document Type: Conference Paper

References (36)

1. Agoram, B., W. S. Woltosz & M. B. Bolger: Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Adv. Drug Deliv. Rev. 2001, 50, S41-67.
2. Amidon, G. L., H. Lennernäs, V P. Shah & J. R. Crison: A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 1995, 12, 413-420.
3. Bassingthwaighte, J. B., L. S. Liebovitch & B. J. West: Fractal physiology. Oxford University Press, New York, 1994.
4. Bonny, J. D. & H. Leuenberger: Matrix type controlled release systems. 1. Effect of percolation on drug dissolution kinetics. Pharm. Acta. Helv. 1991, 66, 160-164.
5. Bunde, A., S. Havlin, R. Nossal, H. E. Stanley & G. H. Weiss: On controlled diffusion-limited drug release from a leaky matrix. J. Chem. Physics 1985, 83, 5909-5913.
6. Dokoumetzidis, A. & P. Macheras: A dispersion - convection model for the study of the gastrointestinal drug absorption. AAPS PharmSci. 2003, 5, Abstract R6086.
7. Dokoumetzidis, A. & P. Macheras: A population growth model of dissolution. Pharm. Res. 1997, 14, 1122-1126.
8. Farin, D. & D. Avnir: Use of fractal geometry to determine effects of surface morphology on drug dissolution. J. Pharm. Sci. 1992, 81, 54-57.
9. FDA: Guidance for industry, waiver of in vivo bioavailability and bioequivalence studies for immediate release solid oral dosage forms based on a biopharmaceutics classification system. CDER/ FDA, Washington DC, USA, 2000.
10. Grass, G. M.: Simulation models to predict oral drug absorption from in vitro data. Adv. Drug Deliv. Rev. 1997, 23, 199-219.
11. Kalampokis, A., P. Argyrakis & P. Macheras: A heterogeneous tube model of intestinal drug absorption based on probabilistic concepts. Pharm. Res. 1999a, 16, 1764-1769.
12. Kalampokis, A., P. Argyrakis & P. Macheras: Heterogeneous tube model for the study of small intestinal transit flow. Pharm. Res. 1999b, 16, 87-91.
13. Kopelman, R.: Fractal reaction kinetics. Science 1988, 241, 1620-1626.
14. Kosmidis, K., P. Argyrakis & P. Macheras: A reappraisal of drug release laws using Monte-Carlo simulations: The prevalence of the Weibull function. Pharm. Res. 2003a, 20, 988-995.
15. Kosmidis, K., P. Argyrakis & P. Macheras: Fractal kinetics in drug release from finite fractal matrices. J. Chem. Phys. 2003b, 119, 6373-6377.
16. Landau, D & K. Binder: A guide to Monte Carlo simulations in statistical physics. Cambridge University Press, Cambridge, UK, 2000.
17. Langenbucher, F.: Linearization of dissolution rate curves by the Weibull distribution. J. Pharm. Pharmacol. 1972, 24, 979-981.
18. Lansky, P. & M. Weiss: Classification of dissolution profiles in terms of fractional dissolution rate and a novel measure of heterogeneity. J. Pharm. Sci. 2003, 92, 1632-1647.
19. Lansky, P. & M. Weiss: Does the dose-solubility ratio affect the mean dissolution time of drugs? Pharm. Res. 1999, 16, 1470-1476.
20. Lansky, P. & M. Weiss: Modeling heterogeneity of properties and random effects in drug dissolution. Pharm Res. 2001, 18, 1061-1067.
21. Macheras, P. & P. Argyrakis: Gastrointestinal drug absorption: is it time to consider heterogeneity as well as homogeneity? Pharm. Res. 1997, 14, 842-847.
22. Macheras, R & A. Dokoumetzidis: On the heterogeneity of drug dissolution and release. Pharm. Res. 2000, 17, 108-112.
23. Ni, P. F., N. H. F. Ho, J. L. Fox, H. Leuenberger & W. I. Higuchi: Theoretical model studies of intestinal drug absorption V. Non-steady-state fluid flow and absorption. Int. J. Pharm. 1980, 5, 33-47.
24. Oh, D. M., R. L. Curl & G. L. Amidon: Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model. Pharm. Res. 1993, 10, 264-270.
25. Rinaki, E., A. Dokoumetzidis & P. Macheras: The mean dissolution time depends on the dose/solubility ratio. Pharm. Res. 2003a, 20, 406-408.
26. Rinaki, E., G. Valsami, & P. Macheras: Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio. Pharm. Res. 2003b, 20, 1917-1925.
27. Rinaki, E., A. Dokoumetzidis, G. Valsami & P. Macheras: Identification of Biowaivers among Class II Drugs: Theoretical Justification and Practical Examples. Pharm. Res. 2004, 21, 1567-1572.
28. Ritger, P. & N. A. Peppas: A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J. Control. Rel. 1987b, 5, 37-42.
29. Ritger, P. & N. A. Peppas: A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J. Contr. Rel. 1987a, 5, 23-36.
30. Siepmann, J. & N. A. Peppas: Hydrophilic matrices for controlled drug delivery: an improved mathematical model to predict the resulting drug release kinetics (the 'sequential layer' model). Pharm. Res. 2000, 17, 1290-1298.
31. Siepmann, J. & N. A. Peppas: Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Del. Rev. 2001, 48, 139-157.
32. Siepmann, J., N. Faisant & J. P. Benoît: A new mathematical model quantifying drug release from bioerodible microparticles using Monte Carlo simulations. Pharm Res. 2002, 19, 1885-1893.
33. Valsami, G. & P. Macheras: Determination of fractal reaction dimension in dissolution studies. Eur. J. Pharm. Sci. 1995, 3, 163-169.
34. Valsami, G., A. Dokoumetzidis & P. Macheras: Modeling of super-saturated dissolution data. Int. J. Pharm. 1999, 181, 153-157.
35. Willmann, S., W. Schmitt, J. Keldenich & J. B. Dressman: A physiologic model for simulating gastrointestinal flow and drug absorption in rats. Pharm. Res. 2003, 20, 1766-1771.
36. Yu, L. X., J. R. Crison & G. L. Amidon: Compartmental transit and dispersion model analysis of small intestinal transit flow in humans. Int. J. Pharm. 1996, 140, 111-118.